Advertisement

Malignant Hyperthermia in Austria 1984–1993

  • Dorrit Heilinger
  • Eva Donner
  • Andrea Sauberer
  • Werner Hackl
  • Walter Mauritz

Abstract

The Vienna Malignant Hyperthermia (MH) Investigation Unit (which functions as the Austrian National MH Registry) was founded in 1976 by Karl Steinbereithner and Paul Sporn. The unit employs three anesthesiologists, one nurse, two technicians, and one secretary (all part-time) and is funded by the Austrian Government, Ministry of Health, the Ludwig-Boltzmann Society, and the University of Vienna Diagnostic testing of MH probands and family members has been performed since 1976. Initially, halothane and halothane-caffeine tests were done, but since the founding of the European MH Group in 1983, the European Protocol [1] has been used. In 1985 a program to provide safe anesthesia for MH patients was established [2]. A hot-line for MH-related problems has operated 24 hours a day since 1987. This paper summarizes the results of our studies on epidemiology and clinical course of MH in Austria. Only patients evaluated according to the European Protocol are included in this report.

Keywords

Succinyl Choline Malignant Hyperthermia Malignant Hyperthermia Malignant Hyperthermia Susceptibility Malignant Hyperpyrexia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The European Malignant Hyperpyrexia Group. (1984) A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 56: 1267CrossRefGoogle Scholar
  2. 2.
    Hackl W, Mauritz W, Winkler M, Sporn P, Steinbereithner K (1990) Anesthesia in malignant hyperthermia susceptible patients without dantrolene prophylaxis—a report of 30 cases. Acta Anaesthesiol Scand 34: 534PubMedCrossRefGoogle Scholar
  3. 3.
    Hackl W, Mauritz W, Schemper M, Winkler M, Sporn P, Steinbereithner K (1990) Prediction of malignant hyperthermia susceptibility: statistical evaluation of clinical signs. Br J Anaesth 64: 425PubMedCrossRefGoogle Scholar
  4. 4.
    Hackl W (1990) Malignant Hyperthermia. Results of diagnostic, clinical, experimental and epidemiological studies. Beitr Anaesth Intens Notfallmed 34. Maudrich ViennaMunich-BerneGoogle Scholar
  5. 5.
    Britt BA (1982) Malignant hyperthermia: A review. In: Milton AS (ed) Pyretics and antipyretics. Handbook of experimental pharmacology, vol 60. Springer, Berlin Heidelberg New York, p 547CrossRefGoogle Scholar
  6. 6.
    Mauritz W, Sporn P, Steinbereithner K (1986) Epidemiological and clinical aspects of 65 cases of Malignant hyperthermia ( MH) in Austria. Anaesthesist 35: 639Google Scholar
  7. 7.
    Mauritz W, Gilly H, Sporn P, Steinbereithner K, Weindlmayr-Goettel M (1986) Isofluorane and malignant hyperthermia. In: Lawin P, Van Aken H, Puchstein C (eds) Isofluorane. Anaesthesie and Intensivemedizin, vol 182. Springer, Berlin Heidelberg New York, p 304Google Scholar
  8. 8.
    Hackl W, Winkler M, Mauritz W, Sporn P, Steinbereithner K (1991) Muscle biopsy for diagnosis of malignant hyperthermia susceptibility in two patients with severe exercise induced myolysis. Br J Anaesth 66: 138PubMedCrossRefGoogle Scholar
  9. 9.
    Britt BA, Kalow W (1970) Malignant hyperthermia: a statistical review. Can Anaesth Soc J 17: 293PubMedCrossRefGoogle Scholar
  10. 10.
    Gjengstö H (1971) Die maligne Hyperpyrexie: eine ernsthafte Narkosekomplikation. Anaesthesist 20: 299PubMedGoogle Scholar
  11. 11.
    Morio M (1980) Malignant hyperthermia (in Japanese with English abstract). Masui (Jpn J Anesthesiol) 29: 1Google Scholar
  12. 12.
    ording H, Ranklev E, Fletcher R (1984) Investigation of malignant hyperthermia in Denmark and Sweden. Br J Anaesth 56: 1183PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1996

Authors and Affiliations

  • Dorrit Heilinger
    • 1
  • Eva Donner
    • 1
  • Andrea Sauberer
    • 1
  • Werner Hackl
    • 2
  • Walter Mauritz
    • 2
  1. 1.Vienna Malignant Hyperthermia Investigation Unit, Department of Anesthesia and Critical Care Medicine B, School of MedicineUniversity of ViennaAustria
  2. 2.Wien-Linz, Vienna DivisionLudwig-Boltzmann Institute of Experimental Anesthesia and Research in Intensive CareViennaAustria

Personalised recommendations